HUE049460T2 - Heterociklusos vegyület és annak alkalmazása ampa receptor pozitív allosztérikus modulátorként - Google Patents

Heterociklusos vegyület és annak alkalmazása ampa receptor pozitív allosztérikus modulátorként

Info

Publication number
HUE049460T2
HUE049460T2 HUE11749944A HUE11749944A HUE049460T2 HU E049460 T2 HUE049460 T2 HU E049460T2 HU E11749944 A HUE11749944 A HU E11749944A HU E11749944 A HUE11749944 A HU E11749944A HU E049460 T2 HUE049460 T2 HU E049460T2
Authority
HU
Hungary
Prior art keywords
heterocyclic compound
positive allosteric
receptor positive
ampa receptor
allosteric modulator
Prior art date
Application number
HUE11749944A
Other languages
English (en)
Inventor
Masakuni Kori
Toshihiro Imaeda
Shinji Nakamura
Masashi Toyofuku
Eiji Honda
Yasutomi Asano
Osamu Ujikawa
Michiyo Mochizuki
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of HUE049460T2 publication Critical patent/HUE049460T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
HUE11749944A 2010-08-10 2011-08-09 Heterociklusos vegyület és annak alkalmazása ampa receptor pozitív allosztérikus modulátorként HUE049460T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010179577 2010-08-10

Publications (1)

Publication Number Publication Date
HUE049460T2 true HUE049460T2 (hu) 2020-09-28

Family

ID=44534564

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE11749944A HUE049460T2 (hu) 2010-08-10 2011-08-09 Heterociklusos vegyület és annak alkalmazása ampa receptor pozitív allosztérikus modulátorként

Country Status (38)

Country Link
US (11) US9150591B2 (hu)
EP (1) EP2603513B1 (hu)
JP (2) JP5788496B2 (hu)
KR (1) KR101852215B1 (hu)
CN (2) CN103180326B (hu)
AR (1) AR082618A1 (hu)
AU (1) AU2011290126B2 (hu)
BR (1) BR112013002250B1 (hu)
CA (1) CA2807460C (hu)
CL (1) CL2013000380A1 (hu)
CO (1) CO6680700A2 (hu)
CR (1) CR20130066A (hu)
CY (1) CY1123507T1 (hu)
DK (1) DK2603513T3 (hu)
DO (1) DOP2013000030A (hu)
EA (1) EA022078B1 (hu)
EC (1) ECSP13012478A (hu)
ES (1) ES2793723T3 (hu)
GE (1) GEP20156216B (hu)
HR (1) HRP20200844T1 (hu)
HU (1) HUE049460T2 (hu)
IL (1) IL224452A (hu)
LT (1) LT2603513T (hu)
MA (1) MA34509B1 (hu)
MX (1) MX349470B (hu)
MY (1) MY165908A (hu)
NZ (1) NZ607593A (hu)
PE (1) PE20131116A1 (hu)
PL (1) PL2603513T3 (hu)
PT (1) PT2603513T (hu)
RS (1) RS60311B1 (hu)
SG (1) SG187656A1 (hu)
SI (1) SI2603513T1 (hu)
TW (1) TWI504604B (hu)
UA (1) UA111594C2 (hu)
UY (1) UY33551A (hu)
WO (1) WO2012020848A1 (hu)
ZA (1) ZA201301120B (hu)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9150591B2 (en) * 2010-08-10 2015-10-06 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
US9527807B2 (en) 2011-04-05 2016-12-27 Takeda Pharmaceutical Company Limited Sulfonamide derivative and use thereof
EP2813508B1 (en) * 2012-02-08 2018-01-31 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
CA2915405A1 (en) * 2013-06-13 2014-12-18 Veroscience Llc Compositions and methods for treating metabolic disorders
BR122023004130B1 (pt) 2013-06-27 2023-12-12 Pfizer Inc Compostos heteroaromáticos, composição farmacêutica e uso dos referidos compostos no tratamento de distúrbios mediados ou associados a dopamina d1
SI3663282T1 (sl) 2013-12-03 2022-08-31 Fmc Corporation Pirolidinonski herbicidi
US11589583B2 (en) 2013-12-03 2023-02-28 Fmc Corporation Pyrrolidinones herbicides
SG11201610720VA (en) 2014-07-02 2017-01-27 Du Pont Piperidinone herbicides
SG11201702924WA (en) 2014-12-08 2017-05-30 Du Pont 3-oxo-3-(arylamino)propanoates, a process for their preparation, and their use in preparing pyrrolidinones
CN107466290B (zh) 2015-04-10 2021-08-03 Fmc公司 作为除草剂的取代的环酰胺
AU2016254958B2 (en) 2015-04-27 2020-04-23 Fmc Corporation Butyrolactones as herbicides
US10513523B2 (en) * 2015-04-29 2019-12-24 Janssen Pharmaceutica Nv Imidazopyrazines and pyrazolopyrimidines and their use as AMPA receptor modulators
CN107835814B (zh) * 2015-04-29 2021-07-23 詹森药业有限公司 氮杂苯并咪唑及其作为ampa受体调节剂的用途
JP7000160B2 (ja) 2015-05-12 2022-01-19 エフ エム シー コーポレーション 除草剤としてのアリール置換二環式化合物
CN107690426B (zh) 2015-05-29 2021-07-06 Fmc公司 作为除草剂的取代的环酰胺
WO2016196593A1 (en) 2015-06-02 2016-12-08 E I Du Pont De Nemours And Company Substituted cyclic amides and their use as herbicides
RU2720994C2 (ru) 2015-07-31 2020-05-15 Е.И.Дюпон Де Немур Энд Компани Новые соединения циклического n-карбоксамида, применяемые в качестве гербицидов
TW201713774A (zh) 2015-08-06 2017-04-16 Kohjin Life Sciences Co Ltd 含有β-菸鹼醯胺單核苷酸的酵母萃取物及其製造方法
CN107709342B (zh) * 2015-08-06 2021-09-03 豪夫迈·罗氏有限公司 制备乙酰半乳糖胺酸衍生物的方法
US20170181292A1 (en) * 2015-12-16 2017-06-22 Rohm And Haas Electronic Materials Llc Method for forming organic coating on nickel surface
CN105669731B (zh) * 2016-01-10 2017-06-30 沧州普瑞东方科技有限公司 一种4‑(4‑烷基环己氧基)苯硼酸的合成方法
RU2019122791A (ru) 2016-12-21 2021-01-25 Фмк Корпорейшн Гербициды на основе нитрона
CN107892697B (zh) 2016-12-26 2020-11-03 郑州泰基鸿诺医药股份有限公司 一种[1,3]噻嗪-2-胺类化合物及应用,药物组合物
KR102620213B1 (ko) 2017-03-21 2024-01-03 에프엠씨 코포레이션 피롤리디논 및 이의 제조 방법
MX2019011090A (es) 2017-03-21 2019-11-18 Fmc Corp Mezcla herbicida, composición y método.
AR111839A1 (es) 2017-05-30 2019-08-21 Fmc Corp Lactamas 3-sustituidas herbicidas
AR111967A1 (es) 2017-05-30 2019-09-04 Fmc Corp Amidas herbicidas
WO2019070043A1 (ja) 2017-10-06 2019-04-11 武田薬品工業株式会社 複素環化合物
JP7250687B2 (ja) 2017-10-06 2023-04-03 武田薬品工業株式会社 複素環化合物
JP2023526249A (ja) * 2020-05-15 2023-06-21 武田薬品工業株式会社 うつ病の処置
CN113943294A (zh) * 2020-07-15 2022-01-18 成都海博为药业有限公司 一种作为btk抑制剂的化合物及其制备方法与用途

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0437742Y2 (hu) 1986-10-22 1992-09-04
JPH0285851A (ja) * 1988-09-22 1990-03-27 Konica Corp 新規な写真用カプラー
JPH037742A (ja) 1989-06-05 1991-01-14 Toyo Tire & Rubber Co Ltd ラバーチエーン用ゴム組成物
JP2874960B2 (ja) * 1990-06-03 1999-03-24 コニカ株式会社 新規な染料を含有するハロゲン化銀写真感光材料
JPH04119890A (ja) 1990-09-11 1992-04-21 Konica Corp ピラゾロチアジアジン系色素
JP3430375B2 (ja) 1993-11-12 2003-07-28 コニカ株式会社 感熱転写材料及び該材料に好適な色素
DE19704923A1 (de) 1997-02-10 1998-08-13 Hoechst Schering Agrevo Gmbh Klebstoffhaltige Schädlingsbekämpfungsmittel
WO2001032013A1 (en) 1999-11-04 2001-05-10 Colorado State University Research Foundation Method and device for attracting insects
FR2801587B1 (fr) 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2458388A1 (en) * 2001-10-10 2003-04-17 Neurosearch A/S Novel benzothiazine derivatives, their preparation and use
FR2833955B1 (fr) * 2001-12-21 2004-01-30 Servier Lab Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2854634B1 (fr) * 2003-05-05 2005-07-08 Servier Lab Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2865474B1 (fr) 2004-01-26 2008-06-13 Servier Lab Nouveaux derives de benzothiazines fluorees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) * 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2655376A1 (en) 2006-06-23 2007-12-27 Nufarm Australia Limited Phenoxy alkanoate herbicidal composition and method of preparation and use
EA015600B1 (ru) * 2006-12-11 2011-10-31 Эли Лилли Энд Компани Агенты, усиливающие действие амра-рецепторов
US20080167374A1 (en) 2007-01-09 2008-07-10 Loveland Products, Inc. Pesticide composition and method of use
CN101910178A (zh) * 2007-11-05 2010-12-08 先灵公司 γ分泌酶调节剂
US8642660B2 (en) * 2007-12-21 2014-02-04 The University Of Rochester Method for altering the lifespan of eukaryotic organisms
JPWO2009119088A1 (ja) 2008-03-25 2011-07-21 武田薬品工業株式会社 複素環化合物
JP2009248543A (ja) * 2008-04-11 2009-10-29 Fujifilm Corp 光情報記録媒体および情報記録方法
TW201012803A (en) 2008-06-06 2010-04-01 Organon Nv Heterocyclic derivatives
WO2010054078A1 (en) * 2008-11-06 2010-05-14 Schering Corporation Gamma secretase modulators
TW201030002A (en) 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
JP2012051806A (ja) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd イミダゾリルピラジン誘導体
FR2943342B1 (fr) 2009-03-20 2011-03-04 Servier Lab Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2010140339A1 (ja) 2009-06-01 2010-12-09 武田薬品工業株式会社 複素環化合物
WO2011007756A1 (ja) 2009-07-13 2011-01-20 武田薬品工業株式会社 複素環化合物及びその用途
WO2011036885A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
WO2011036889A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
US9150591B2 (en) * 2010-08-10 2015-10-06 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof

Also Published As

Publication number Publication date
US11279713B2 (en) 2022-03-22
MX2013001614A (es) 2013-07-05
US20190263832A1 (en) 2019-08-29
US9150591B2 (en) 2015-10-06
PL2603513T3 (pl) 2020-07-27
KR101852215B1 (ko) 2018-04-25
EP2603513A1 (en) 2013-06-19
GEP20156216B (en) 2015-01-12
ECSP13012478A (es) 2013-04-30
CA2807460A1 (en) 2012-02-16
SI2603513T1 (sl) 2020-07-31
UA111594C2 (uk) 2016-05-25
CN104926837A (zh) 2015-09-23
US10654874B2 (en) 2020-05-19
RS60311B1 (sr) 2020-07-31
US20180162875A1 (en) 2018-06-14
NZ607593A (en) 2015-01-30
BR112013002250B1 (pt) 2020-10-27
CN103180326A (zh) 2013-06-26
CO6680700A2 (es) 2013-05-31
BR112013002250A2 (pt) 2016-05-24
US8778934B2 (en) 2014-07-15
CR20130066A (es) 2013-05-03
HRP20200844T1 (hr) 2020-08-21
KR20130138738A (ko) 2013-12-19
US8575154B2 (en) 2013-11-05
WO2012020848A8 (en) 2012-09-27
MY165908A (en) 2018-05-18
US9499568B2 (en) 2016-11-22
US20150073137A1 (en) 2015-03-12
US20200317692A1 (en) 2020-10-08
JP2016006080A (ja) 2016-01-14
LT2603513T (lt) 2020-05-25
TW201217386A (en) 2012-05-01
EA022078B1 (ru) 2015-10-30
US20140080817A1 (en) 2014-03-20
AU2011290126B2 (en) 2016-01-07
MA34509B1 (fr) 2013-09-02
PE20131116A1 (es) 2013-10-24
CA2807460C (en) 2018-09-18
EP2603513B1 (en) 2020-03-11
US20130190291A1 (en) 2013-07-25
UY33551A (es) 2012-03-30
JP6113789B2 (ja) 2017-04-12
US8916551B2 (en) 2014-12-23
SG187656A1 (en) 2013-03-28
US20130184266A1 (en) 2013-07-18
DOP2013000030A (es) 2013-03-15
ZA201301120B (en) 2014-04-30
TWI504604B (zh) 2015-10-21
MX349470B (es) 2017-07-31
WO2012020848A1 (en) 2012-02-16
IL224452A (en) 2017-11-30
ES2793723T3 (es) 2020-11-16
CL2013000380A1 (es) 2013-05-31
DK2603513T3 (da) 2020-06-15
CY1123507T1 (el) 2022-03-24
AR082618A1 (es) 2012-12-19
US20240360156A1 (en) 2024-10-31
US9884875B2 (en) 2018-02-06
US20120077799A1 (en) 2012-03-29
EA201390222A1 (ru) 2013-08-30
PT2603513T (pt) 2020-06-08
JP5788496B2 (ja) 2015-09-30
CN103180326B (zh) 2015-06-10
US20170022222A1 (en) 2017-01-26
AU2011290126A1 (en) 2013-03-07
US20150353578A1 (en) 2015-12-10
JP2013535408A (ja) 2013-09-12

Similar Documents

Publication Publication Date Title
LT2603513T (lt) Heterociklinis junginys ir jo panaudojimas kaip ampa receptoriaus teigiamo alosterinio moduliatoriaus
IL246600B (en) Heterocyclic compounds and their use
IL222288A0 (en) Heterocyclic compounds and their uses
EP2637669A4 (en) Heterocyclic compounds and their use
IL225770A0 (en) Heterocyclic compounds
EP2575462A4 (en) Heterocyclic compounds and their use
IL221442A0 (en) Heterocyclic compound
EP2579717A4 (en) POSITIVE ALLOSTERIC MODULATORS OF MGLUR2
EP2603079A4 (en) POSITIVE ALLOSTERIC MODULATORS OF MGLUR2
ZA201300950B (en) Heterocyclic compound
EP2542083A4 (en) POSITIVE ALLOSTERIC MODULATORS OF MGLUR2
EP2604597A4 (en) HETEROCYCLIC COMPOUND AND USE THEREOF
EP2582241A4 (en) HETEROCYCLIC FUSIONED PHENANTHROLINONE COMPOUNDS USEFUL AS POSITIVE ALLOSERIC MODULATORS OF THE M1 RECEPTOR
EP2563126A4 (en) POSITIVE ALLOSTERIC MODULATORS OF M1 RECEPTOR DERIVED FROM HETEROCYCLIC QUINOLIZINE
ZA201306586B (en) Thynyl derivatives as positive allosteric modulators of the mglur5
ZA201300157B (en) Fused heterocyclic derivatives as s1p modulators
EP2597095A4 (en) FUSED HETEROCYCLIC COMPOUND AND APPLICATION THEREOF
EP2583965A4 (en) HETEROCYCLIC RING CONNECTION
GB2477949B (en) Powering of devices
PL2769720T3 (pl) Heterocykliczne allosteryczne modulatory gsk-3
GB201021416D0 (en) Novel heterocyclic compounds
GB201009514D0 (en) Novel heterocyclic compounds